Cetera Advisors LLC Moderna, Inc. Transaction History

Cetera Advisors LLC

$0
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $718,730 - $971,889	8,419 Added 198.09%	12,669 $1.35 Million
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $82,299 - $123,645	-1,184 Reduced 21.79%	4,250 $422,000
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $16,678 - $21,903	173 Added 3.29%	5,434 $561,000
Q2 2023 Aug 09, 2023	SELL	$118.5 - $160.53 $1,540 - $2,086	-13 Reduced 0.25%	5,261 $639,000
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $47,616 - $69,154	-351 Reduced 6.24%	5,274 $809,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $57,295 - $101,659	484 Added 9.41%	5,625 $1.01 Million
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $94,692 - $155,732	-802 Reduced 13.49%	5,141 $608,000
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $34,670 - $52,270	296 Added 5.24%	5,943 $849,000
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $979,559 - $1.82 Million	-7,746 Reduced 57.84%	5,647 $973,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $322,922 - $526,969	-1,430 Reduced 9.65%	13,393 $3.4 Million
Q3 2021 Nov 16, 2021	BUY	$221.9 - $484.47 $192,387 - $420,035	867 Added 6.21%	14,823 $5.71 Million
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $67,033 - $121,249	-516 Reduced 3.57%	13,956 $3.28 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $53,389 - $90,944	489 Added 3.5%	14,472 $1.9 Million
Q4 2020 Feb 17, 2021	BUY	$65.74 - $169.86 $80,400 - $207,738	1,223 Added 9.58%	13,983 $1.46 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $22,714 - $39,647	418 Added 3.39%	12,760 $903,000
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $366,187 - $987,360	12,342 New	12,342 $792,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.

Account